FDA approves Lipitor for reducing heart attack risk
August 5, 2004The FDA has approved Pfizer's cholesterol-lowering statin Lipitor for a new indication – the prevention of cardiovascular disease by reducing …
Pharma to work with NPC on pre-launch updates
August 4, 2004News of new medicines on the horizon should be communicated better and earlier to NHS clinicians and managers following a …
‘Double boost’ for Seoquel in bipolar disorder and dementia
August 4, 2004AstraZeneca announced a 'double boost' for its atypical antipsychotic Seroquel as it gained FDA approval for the long-term treatment of …
Lilly to disclose clinical trial results
August 4, 2004Lilly has responded to calls for greater disclosure of clinical trial results by pledging to publish more data through its …
Turning clinical trials on their head
August 4, 2004Increased pressure to get more products to market faster, with a close eye on the total cost of development and …
Trading places and switching sides
July 29, 2004Power, intrigue, corruption and more than a dash of Hollywood: yes, the Mafia has it all. And just like La …
New diabetes drug superior to Lantus, says Lilly
July 29, 2004Amylin Pharmaceuticals and partners Lilly say patients taking their new diabetes drug exenatide achieved similar glycaemic control to those on …
‘Patents versus patients’ still part of the problem
July 26, 2004The head of the UN AIDS programme has said there must be an end to divisive "institutional agendas" and greater …
Vytorin poised to benefit from controversial US guidelines
July 26, 2004New US guidelines for lowering cholesterol targets in at-risk patients have stirred controversy after experts were accused of not declaring …
R&D chief loses his cool over Swedish attitude
July 26, 2004AstraZeneca says it remains committed to its research operations in Sweden – with its headquarters south-west of Stockholm – after …
Merck enlist Avenue for Erbitux launch
July 22, 2004Merck UK has launched its first cancer treatment, Erbitux, with a communications programme led by Avenue HKM.Avenue was selected after …
Targets out and standards in for next NHS three-year plan
July 22, 2004The government has unveiled its masterplan for the NHS in the three years from 2005/6, slashing the number of national …
Falling stars blight NHS performance ratings
July 21, 2004Four of the government's flagship foundation trusts have lost their three star ratings in the latest review, prompting further criticism …
New Europe: always read the label
July 21, 2004In May 2004, ten emerging economies across the east of Europe became members of the European Union. This might seem …
Half a million asthma patients suffering unnecessarily
July 20, 2004More than half a million people in the UK suffer an asthma attack every day, with a further million putting …
